Evaluation of the Nutritional Status of Gaucher Disease Type I Patients under Enzyme Replacement Treatment.
Gaucher disease
energy metabolism
indirect calorimetry
nutritional status
resting energy expenditure
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
03 Aug 2022
03 Aug 2022
Historique:
received:
19
06
2022
revised:
28
07
2022
accepted:
31
07
2022
entrez:
12
8
2022
pubmed:
13
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
(1) Background: Gaucher disease (GD) is a rare lysosomal storage disease. The few studies analyzing Resting Energy Expenditure (REE) in GD involved mainly untreated patients and supported a hypermetabolic condition possibly due to the associated inflammatory state. Definitive conclusions could not be drawn also because of the heterogeneity and the small size of the samples investigated. In order to expand current knowledge concerning, in particular the condition of patients under Enzyme Replacement Therapy (ERT), we evaluated the nutritional status of a relatively large sample of GD patients followed at Federico II University Hospital in Naples, Italy. (2) Methods: The study, having a cross-sectional design and involving 26 patients on ERT, included routine biochemical analyses, bioelectrical impedance analysis, indirect calorimetry, and administration of food frequency and physical activity questionnaires. The results in GD patients were compared with those from an appropriate control group. (3) Results: GD patients had normal biochemical parameters in 80% of cases, except for HDL-cholesterol, consumed a hyper-lipidic diet, and had a 60% prevalence of overweight/obesity. Body composition did not differ between patients and controls; however, measured REE was significantly lower than predicted and was reduced in comparison with the healthy controls. (4) Conclusions: This study provided novel elements to the present knowledge about REE and the nutritional status of GD patients under ERT. Its results warrant confirmation in even larger GD population samples and a more in-depth investigation of the long-term effects of treatment superimposed on the basic pathophysiological disease condition.
Identifiants
pubmed: 35956356
pii: nu14153180
doi: 10.3390/nu14153180
pmc: PMC9370155
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Am J Med. 1997 Sep;103(3):185-91
pubmed: 9316550
Orphanet J Rare Dis. 2019 Dec 2;14(1):275
pubmed: 31791361
Am J Clin Nutr. 2005 Jan;81(1):74-8
pubmed: 15640463
Int J Food Sci Nutr. 2015;66(4):426-38
pubmed: 25830946
Am J Clin Nutr. 1988 Apr;47(4):591-607
pubmed: 3281433
J Physiol. 1949 Aug;109(1-2):1-9
pubmed: 15394301
J Inherit Metab Dis. 2013 May;36(3):555-63
pubmed: 22976766
Proc Natl Acad Sci U S A. 1918 Dec;4(12):370-3
pubmed: 16576330
Orphanet J Rare Dis. 2019 Sep 5;14(1):212
pubmed: 31488169
Metabolism. 1989 Dec;38(12):1238-43
pubmed: 2593834
Blood Cells Mol Dis. 2011 Jan 15;46(1):42-6
pubmed: 21075022
Haematologica. 2021 Feb 01;106(2):437-445
pubmed: 32001533
Blood Cells Mol Dis. 2008 May-Jun;40(3):428-32
pubmed: 17950007
J Clin Med. 2020 Jan 14;9(1):
pubmed: 31947532
Epidemiol Prev. 2015 Sep-Dec;39(5-6):373-9
pubmed: 26554689
J Clin Endocrinol Metab. 1995 Sep;80(9):2653-7
pubmed: 7673407
Public Health Nutr. 2006 Apr;9(2):258-65
pubmed: 16571181
Int J Mol Sci. 2017 Feb 17;18(2):
pubmed: 28218669
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Nutrition. 2021 Apr;84:111105
pubmed: 33477001
N Engl J Med. 1991 May 23;324(21):1464-70
pubmed: 2023606
Lancet. 2008 Oct 4;372(9645):1263-71
pubmed: 19094956